The report on the Global Oral Proteins Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue and volume (USD MN/ Kilo Tons) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Oral proteins are delivery of active proteins through oral route. The therapeutically active proteins have been administered to the human body through intravenous or subcutaneous routes for treating diseases like diabetes, cancer, infectious diseases, hemophilia, anemia etc. However, these administrative method results into patient’s inconvenience due to frequent injections, repetitive therapies, increased cost involved by healthcare professional and maintaining hygienic conditions. The oral delivery route of these macromolecules is long being researched as it has high levels of patient acceptance and convenience.
Report includes a detailed analysis on value chain in order to provide a holistic view of the oral proteins market. Value chain analysis comprises detailed evaluation of the roles of various players involved in the oral proteins industry, from raw material suppliers to end-users.
Porter’s five forces model has been used to depict the impact of various factors such as:
- Degree of competition
- Bargaining power of suppliers
- Threat of substitutes
- Bargaining power of buyers
- Threat of new entrants during the forecast period
Market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
The oral proteins market has further been segmented based on drugs such as Linaclotide, IN-105 (Inslulin), Ostora, Octreolin, Plecantide and others. The study provides forecast and estimates market for each type in terms of revenue and volume during the forecast period from 2020 to 2026. Each type has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
The oral proteins market has been segmented based on formulation technology such as gastrointestinal permeation enhancement technology (GIPET), eligen, oral antibody platform, Multi-Matrix Systems (MMX) and others. The study provides forecast and estimates market for each application in terms of revenue and volume during the forecast period from 2020 to 2026. Each application has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
In terms of geography, the oral proteins market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue and volume during the forecast period.
The report also offers a competitive landscape of the overall market with company profiles of players such as:
- Abbott Laboratories
- Biocon
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
- Roche, Inc.
- Sanofi-Aventis LLC
- ZydusCadilla Healthcare
A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments provides a thorough idea about the competitive positioning of market players. The report also provides oral proteins market's Mergers/acquisitions, Partnerships, Collaborations, New product lunches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Oral Proteins By Drugs:
- Linaclotide
- IN-105 (Inslulin)
- Ostora
- Octreolin
- Plecantide
- Others
Oral Proteins By Formulations Technology:
- Gastrointestinal Permeation Enhancement Technology (GIPET)
- Eligen
- Oral Antibody Platform
- Multi-Matrix Systems (MMX)
- Others
Oral Proteins By Geography:
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East And Africa
The Global Oral Proteins Market has been exhibited in detail in the following chapters -
Chapter 1 Oral Proteins Market Preface
Chapter 2 Executive Summary
Chapter 3 Oral Proteins Industry Analysis
Chapter 4 Oral Proteins Market Value Chain Analysis
Chapter 5 Oral Proteins Market Analysis By Drugs
Chapter 6 Oral Proteins Market Analysis By Technology
Chapter 7 Oral Proteins Market Analysis By Geography
Chapter 8 Competitive Landscape Of Oral Proteins Companies
Chapter 9 Company Profiles Of Oral Proteins Industry
METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.